Prof. HANDE MEFKURE ÖZKAYA

1. Crooke Cell Adenoma: Is Its Aggressiveness Overestimated? Evidence From a Single-Centre Experience

Muradov I., ŞAHİN S., AKPINAR T. S., Tunc A., Kocaman B. B., Soltanova L., et al.

Clinical Endocrinology , vol.104, no.6, pp.647-656, 2026 (SCI-Expanded, Scopus)

2. Facial Analysis in Acromegaly Using Machine Learning: Toward Earlier Diagnosis

Kocaman B. B., Akkol O. R., Onay G., Bektas A. B., Sahin S., Muradov I., et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , vol.111, no.3, 2026 (SCI-Expanded, Scopus) Sustainable Development

3. Circadian rhythm proteins as potential biomarkers in pituitary adenomas: an immunohistochemical analysis

Uysal S., Karaca E., Saricoban C. T., ŞAHİN S., ÇOMUNOĞLU N., TANRIÖVER N., et al.

Pituitary , vol.29, no.1, 2026 (SCI-Expanded, Scopus)

4. Life activities of elderly patients with operated nonfunctional pituitary adenoma

KARA Z., Avci S., Melikoglu S. E., Sulu C., DEMİR A. N., UYSAL S., et al.

Frontiers in Endocrinology , vol.17, 2026 (SCI-Expanded, Scopus)

5. Beyond MRI: Unveiling metabolic signatures of primary hypophysitis with 18F-FDG PET

ŞAHİN S., Kocaman B. B., Yanmaz M. U., Biyikoglu S. E., Korkmaz O. P., DURCAN E., et al.

Journal of Endocrinological Investigation , 2026 (SCI-Expanded, Scopus)

6. Revisiting mortality in acromegaly using machine learning

Sulu C., ONAY G., Bakhdiyarli G., ŞAHİN S., DURCAN E., Kara Z., et al.

ENDOCRINE , vol.90, no.3, pp.1423-1437, 2025 (SCI-Expanded, Scopus) Sustainable Development

7. The frequency of polycystic ovary syndrome in women with prediabetes compared with normoglycemic women

Sulu C., Pervaz I., Gurer T., Yildiz D., Tas A., Demir A. N., et al.

FRONTIERS IN ENDOCRINOLOGY , vol.16, 2025 (SCI-Expanded, Scopus)

8. The predictors of mortality in patients with acromegaly: an old debate revisited by machine learning

Sulu C., ONAY G., Bakhdiyarli G., Sahin S., Durcan E., Kara Z., et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY , vol.193, pp.1, 2025 (SCI-Expanded, Scopus)

9. Elevated thyroglobulin levels in fine-needle aspiration washout fluid from thyroid nodules: a potential marker of benign nature?

Uysal S., Sulu C., Kocaman B. B., Muradov I., Soltanova L., ŞAHİN S., et al.

ENDOKRYNOLOGIA POLSKA , vol.76, no.4, pp.397-402, 2025 (SCI-Expanded, Scopus) Sustainable Development

10. Associations Between Emotion Regulation Difficulties, Depression, Anxiety Levels, and Disordered Eating Behavior in Adults with Type 1 Diabetes

USTA SAĞLAM N. G., Uysal S., DURCAN E., Yoldas S., Altunel M. R., Capar M. U., et al.

ENDOCRINOLOGY RESEARCH AND PRACTICE , vol.29, no.3, 2025 (ESCI, Scopus, TRDizin) Sustainable Development

11. Impact of disease activity on cognitive and psychological outcomes in acromegaly: A prospective study

UYSAL S., Kara Z., Sulu C., ŞAHİN S., Demir A. N., Gungormus E., et al.

Growth Hormone and IGF Research , vol.81, 2025 (SCI-Expanded, Scopus)

12. Machine Learning May Be an Alternative to BIPSS in the Differential Diagnosis of ACTH-dependent Cushing Syndrome

Demir A. N., Ayata D., Öz A., Sulu C., Kara Z., Sahin S., et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , vol.110, no.2, 2025 (SCI-Expanded, Scopus) Sustainable Development

13. Optimizing Care for Primary Glomerulonephritis: The Role of Thyroid Evaluation.

Demir A. N., Karaca C., Kara Z., Sulu C., Sahin S., Durcan E., et al.

Endocrine, metabolic & immune disorders drug targets , vol.25, pp.905-914, 2025 (SCI-Expanded, Scopus)

14. Knowledge and attitudes of primary care physicians regarding acromegaly: a survey study with multinational participation

Fenercioğlu A., Demircan E. U., Can G., Sulu C., Sipahioğlu N., Özkaya H. M., et al.

BMC PRIMARY CARE , vol.25, no.1, 2024 (SCI-Expanded, Scopus)

15. The association between change in temporal muscle mass and treatment of acromegaly

ŞAHİN S., ÖZ A., Saglamer B., Sulu C., Demir A. N., Soltanova L., et al.

Growth Hormone and IGF Research , vol.79, 2024 (SCI-Expanded, Scopus)

16. Vertebral Fractures Increase the Long-Term Mortality of Patients with Coronavirus Disease 2019

SULU C., Aktas E., Sahin S., DURCAN E., KURUĞOĞLU S., KADIOĞLU P., et al.

ENDOCRINOLOGY RESEARCH AND PRACTICE , vol.28, no.4, pp.197-204, 2024 (ESCI, Scopus, TRDizin) Sustainable Development

17. Evaluation and follow-up of patients diagnosed with hypophysitis: A cohort study

HACIOĞLU A., Karaca Z., UYSAL S., ÖZKAYA H. M., Kadioglu P., Selcukbiricik O. S., et al.

European Journal of Endocrinology , vol.191, no.3, pp.312-322, 2024 (SCI-Expanded, Scopus)

18. Carotid Intima–Media Thickness May Be a Useful Biomarker in Determining Early Cardiovascular Risk in Mild Autonomic Cortisol Hypersecretion

DEMİR A. N., DURCAN E., ÖZKAYA H. M., HALİLOĞLU Ö., KESKİN F. E., KADIOĞLU P.

Cerrahpaşa Medical Journal , vol.47, no.2, pp.119-124, 2024 (TRDizin)

19. The Association Between Oxidative Stress and Sperm Parameters in Patients with Acromegaly

ŞAHİN S., ÇİÇEK E., KOCAMAN B. B., SULU C., ÖZKAYA H. M., Ozkara H., et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.132, no.9, pp.498-506, 2024 (SCI-Expanded, Scopus)

20. The Effect of Metformin Treatment on Disease Control in Patients with Acromegaly

Sahin H. R., ŞAHİN S., Sarac B., Sulu C., KADIOĞLU P., ÖZKAYA H. M.

Endocrine, Metabolic and Immune Disorders - Drug Targets , vol.24, no.6, pp.709-716, 2024 (SCI-Expanded, Scopus)

21. The effect of radioiodine therapy on blood cell count in patients with differentiated thyroid cancer.

Demir A. N., Kara Z., Sulu C., Uysal S., Zulfaliyeva G., Atar O. A., et al.

Hormones (Athens, Greece) , vol.22, no.4, pp.595-602, 2023 (SCI-Expanded, Scopus)

22. The Association between Serum 25-Hydroxyvitamin D3 Levels and Pro-Inflammatory Markers in New-Onset Type 2 Diabetes Mellitus and Prediabetes

Fenercioğlu A., Gönen M. S., Uzun H., Sipahioğlu N., Can G., Tas E., et al.

BIOMOLECULES , vol.13, no.12, 2023 (SCI-Expanded, Scopus)

23. Do not forget the kidney in graves' disease

Demir A. N., Kara Z., Durcan E., Sulu C., Atar O. A., Zulfaliyeva G., et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.55, no.10, pp.2667-2673, 2023 (SCI-Expanded, Scopus) Sustainable Development

24. Risk of impulse control disorders in patients with Cushing's disease: do not blame cabergoline but do not give up caution

Sulu C., Gul N., Tanrikulu S., Ciftci S., Yener Ozturk F., Sarac B., et al.

PITUITARY , vol.26, no.4, pp.495-509, 2023 (SCI-Expanded, Scopus) Sustainable Development

25. Is There A Connection Between Primary Hypophysitis and Celiac Disease?

Kara Z., EŞKAZAN T., ŞAHİN S., Durcan E., Sulu C., Demir A. N., et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.132, no.1, pp.33-38, 2023 (SCI-Expanded, Scopus) Sustainable Development

26. The Combination of Dopamine Agonist Treatment and Surgery May Be the Best Option in Challenging Prolactinoma Cases: A Single-Centre Experience

Demir D., Demir A. N., Sulu C., Zulfaliyeva G., Cetintas S. C., Ozkaya H. M., et al.

World Neurosurgery , vol.175, 2023 (SCI-Expanded, Scopus)

27. A Genetic Assessment of Dopamine Agonist-Induced Impulse Control Disorder in Patients With Prolactinoma

Sahin S., Sudutan T., Kavla Y., Durcan E., Özogul Y. Y., Poyraz B. Ç., et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , vol.108, no.6, 2023 (SCI-Expanded, Scopus) Sustainable Development

28. Visceral Adiposity Index as an Indicator of Cardiometabolic Risk in Patients with Congenital Adrenal Hyperplasia

Kara Z., Demir A. N., Sulu C., Durcan E., Uysal S., Turan H., et al.

METABOLIC SYNDROME AND RELATED DISORDERS , vol.21, no.1, pp.35-40, 2023 (SCI-Expanded, Scopus) Sustainable Development

29. Problem-solving therapy can reduce psychological distress in patients with Cushing's disease: a randomized controlled trial

SULU C., Kaynak G. K., Koskun T., KOCA O., Icli T. B., KAVLA Y., et al.

PITUITARY , vol.25, no.6, pp.891-902, 2022 (SCI-Expanded, Scopus) Sustainable Development

30. Does the Association of Hashimoto's Thyroiditis with Differentiated Thyroid Cancer Really Have a Protective Role?

Demir A. N., Kara Z., Sulu C., Uysal S., Sahin S., Zulfaliyeva G., et al.

HORMONE AND METABOLIC RESEARCH , vol.55, no.6, pp.388-394, 2022 (SCI-Expanded, Scopus) Sustainable Development

31. Fertility Desire and Motivation Among Individuals with Gender Dysphoria: A Comparative Study

DURCAN E., TURAN Ş., Bircan B. E., YAYLAMAZ S., Okur I., DEMİR A. N., et al.

JOURNAL OF SEX & MARITAL THERAPY , vol.48, no.8, pp.789-803, 2022 (SSCI, Scopus) Sustainable Development

32. Effect of metformin on thyroid cancer risk in patients with acromegaly: A preliminary observational study

SULU C., Bektas A. B., Guzel S., TAY K., ŞAHİN S., Durcan E., et al.

GROWTH HORMONE & IGF RESEARCH , 2022 (SCI-Expanded, Scopus) Sustainable Development

33. Endocrinological Follow-Up Characteristics of People Diagnosed with Gender Dysphoria in Turkey

DURCAN E., SULU C., ŞAHİN S., GIOVENTIKLI A., DEDEOĞLU S. E., Azamet I., et al.

TRANSGENDER HEALTH , vol.7, pp.250-260, 2022 (SCI-Expanded, Scopus) Sustainable Development

34. Machine learning as a clinical decision support tool for patients with acromegaly.

Sulu C., Bektas A. B., Sahin S., DURCAN E., KARA Z., DEMİR A. N., et al.

Pituitary , vol.25, no.3, pp.486-495, 2022 (SCI-Expanded, Scopus)

35. The Association Between Somatostatin Receptor Ligand and Vitamin B12 in Patients with Acromegaly

ŞAHİN S., EŞKAZAN T., ÇİÇEK E., Ozogul Y. Y., Durcan E., SULU C., et al.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , no.2, pp.67-72, 2022 (ESCI, Scopus, TRDizin) Sustainable Development

36. Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging-derived texture features

ŞAHİN S., Yildiz G., Oguz S. H., Civan O., Cicek E., DURCAN E., et al.

PITUITARY , vol.25, no.3, pp.474-479, 2022 (SCI-Expanded, Scopus)

37. Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia

Durcan E., Ozkan S., Saygi H. I., Dincer M. T., Korkmaz O. P., Sahin S., et al.

JOURNAL OF DIABETES , vol.14, no.4, pp.236-246, 2022 (SCI-Expanded, Scopus) Sustainable Development

38. Transphobic Attitudes of Physicians Who Play an Active Role in the Gender-Affirming Treatment in Turkey

DURCAN E., Kavla Y., Sahin S., Korkmaz O. P., Durcan G., ÖZKAYA H. M., et al.

SEXUALITY RESEARCH AND SOCIAL POLICY , vol.19, no.1, pp.1-11, 2022 (SSCI, Scopus) Sustainable Development

39. Fibroblast Growth Factor Receptor-4 Expression in Pituitary Adenomas is Associated with Aggressive Tumor Features

DURCAN E., Keskin F. E., ÖZKAYA H. M., ŞİROLU S., ŞAHİN S., Korkmaz O. P., et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.130, no.02, pp.125-133, 2022 (SCI-Expanded, Scopus)

40. Pasireotide treatment in Cushing?s disease: A single tertiary center?s experience

ŞAHİN S., KARİMOVA G., ÖZCAN Ş. G., Durcan E., ÖZKAYA H. M., KADIOĞLU P.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.2, pp.467-476, 2022 (SCI-Expanded, Scopus, TRDizin)

41. TransCOVID: Does Gender-Affirming Hormone Therapy Play a Role in Contracting COVID-19?

Durcan E., Turan Ş., Bircan B. E., Yaylamaz S., Demirel Ö., Demir A. N., et al.

JOURNAL OF SEX & MARITAL THERAPY , vol.48, no.4, pp.415-426, 2022 (SSCI, Scopus) Sustainable Development

42. Relationship between hematologic inflammatory indices and clinical findings in patients with acromegaly

Durcan E., Karabulut D., Yaylamaz S., Sahin S., Sulu C., Taze S., et al.

International Journal of Medical Biochemistry , vol.5, no.3, pp.158-165, 2022 (Scopus, TRDizin)

43. Evaluation of sex hormone profile and semen parameters in acromegalic male patients.

Yilmaz M. K., Sulu C., Ozkaya H. M., Kadioglu A., Ortac M., Kadioglu P.

Journal of endocrinological investigation , vol.44, no.12, pp.2799-2808, 2021 (SCI-Expanded, Scopus)

44. Denosumab and Bisphosphonate Treatment of Osteoporosis in Renal Transplant Recipients

Şahin S., , Dinçer M. T., Seyhan D., Bakır A., Korkmaz Ö. P., et al.

Cerrahpasa Medical Journal , vol.45, no.3, pp.152-158, 2021 (Peer-Reviewed Journal)

45. Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1

Gönen M. S., Alaylıoğlu M., Durcan E., Özdemir Y., Şahin S., Konukoğlu D., et al.

NUTRIENTS , no.11, 2021 (SCI-Expanded, Scopus)

46. Association between β arrestin 2 and filamin A gene variations with medical treatment response in acromegaly patients.

Akdemir A. S., Metin Armagan D., Polat Korkmaz O., Ozkaya H. M., Kadioglu P., Gazioglu N., et al.

Minerva endocrinology , 2021 (SCI-Expanded, Scopus)

47. The Role of Obesity in Predicting the Clinical Outcomes of COVID-19

ŞAHİN S., Sezer H., ÇİÇEK E., Yagiz Ozogul Y., YILDIRIM M., Icli T. B., et al.

OBESITY FACTS , vol.14, no.5, pp.481-489, 2021 (SCI-Expanded, Scopus) Sustainable Development

48. Effectiveness of Cabergoline Treatment in Patients with Acromegaly Uncontrolled with SSAs: Experience of a Single Tertiary Center

ŞAHİN S., FİDAN M. C., Korkmaz O. P., DURCAN E., ÖZKAYA H. M., KADIOĞLU P.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.129, no.9, pp.644-650, 2021 (SCI-Expanded, Scopus)

49. SNPs of miR-23b, miR-107 and HMGA2 and their Relations with the Response to Medical Treatment in Acromegaly Patients

Armagan D., Akdemir A., Ozkaya H. M., Korkmaz O., Gazioglu N., Kadioglu P., et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.129, no.8, pp.593-600, 2021 (SCI-Expanded, Scopus)

50. Can "VAI" Better Indicate Metabolic Syndrome Compared with Other Metabolic Syndrome-Related Parameters in Patients with Thyroid Nodules? A Study from Turkey

DURCAN E., ŞAHİN S., DEDEOĞLU S. E., ÖZKAYA H. M., GÖNEN M. S.

METABOLIC SYNDROME AND RELATED DISORDERS , vol.19, pp.358-366, 2021 (SCI-Expanded, Scopus)

51. T2-weighted magnetic resonance imaging as a novel predictor of surgical remission in newly diagnosed pituitary macroadenomas presenting as acromegaly

Akkaya E., Akgun M. Y., DURMAZ E. Ş., AYDIN S., ÖZKAYA H. M., ÇOMUNOĞLU N., et al.

JOURNAL OF CLINICAL NEUROSCIENCE , vol.90, pp.105-111, 2021 (SCI-Expanded, Scopus)

52. Psychosocial effects and clinic reflections of the COVID-19 outbreak in patients with acromegaly and Cushing's disease

DURCAN E., TURAN Ş., Sahin S., Sulu C., Taze S. S., Kavla Y., et al.

PITUITARY , vol.24, no.4, pp.589-599, 2021 (SCI-Expanded, Scopus)

58. Patients with acromegaly might not be at higher risk for dopamine agonist- induced impulse control disorders than those with prolactinomas

Ozkaya H. M., Sahin S., Korkmaz O. P., Durcan E., Sahin H. R., Celik E., et al.

GROWTH HORMONE & IGF RESEARCH , vol.55, 2020 (SCI-Expanded, Scopus)

59. Baseline Visual Acuity of Women with Diabetic Macular Edema is Worse than Men: A Case-Control Study

Ozkaya A., , Ozkaya H. M., Tarakcioglu H. N., Ozveren M., Demircan A., et al.

THE OPHTHALMOLOGY OPEN JOURNAL , vol.2, no.2, pp.52-57, 2017 (Peer-Reviewed Journal)

60. Anti-Yo-associated cerebellar syndrome presenting with a brain mass

TÜZÜN E., Bektas H. M., İÇÖZ S., KÜRTÜNCÜ M., SAİP P. M., Akman-Demir G.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY , vol.144, no.2, pp.183-184, 2009 (SCI-Expanded, Scopus)

Publications & Works

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Project

Open Access